Richard A. Bender
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 31
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 6
-
- Breast Cancer Treatment Studies 13
- Co-authors
- Don V. JacksonRobert C. YoungBruce A. ChabnerManford C. CastleRichard I. FisherMark G. ErlanderVincent T. DeVitaTom Anderson
- Journals
- Journal of Clinical Oncology (13 papers)Cancer (3 papers)American Journal of Hematology (3 papers)Blood (3 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Richard A. Bender
67 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 514
- Oncology 857
- Reproductive Medicine 239
- Pathology and Forensic Medicine 257
- Pharmacology 80
Countries citing papers authored by Richard A. Bender
This map shows the geographic impact of Richard A. Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Bender more than expected).
Fields of papers citing papers by Richard A. Bender
This network shows the impact of papers produced by Richard A. Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Bender. The network helps show where Richard A. Bender may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard A. Bender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2022 | 13 | |
| 3 | 2021 | 15 | |
| 4 | 2017 | 34 | |
| 5 | 2015 | 22 | |
| 6 | 2013 | 48 | |
| 7 | 2011 | 93 | |
| 8 | 2011 | 2 | |
| 9 | 2010 | 178 | |
| 10 | 2010 | 8 | |
| 11 | 2009 | 75 | |
| 12 | 2009 | 41 | |
| 13 | 2007 | 51 | |
| 14 | 2004 | 9 | |
| 15 | 2003 | 2 | |
| 16 | 1989 | 6 | |
| 17 | Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells. | 1978 | 25 |
| 18 | The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. | 1977 | 17 |
| 19 | Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients. | 1977 | 8 |
| 20 | A crack in the rear-view mirror : a view of industrialized building | 1973 | 5 |
About Richard A. Bender
Richard A. Bender is a scholar working on Oncology, Cancer Research, Hematology, Pathology and Forensic Medicine and Genetics, having authored 69 papers that have together received 1.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Genetic factors in colorectal cancer (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Cancer therapeutics and mechanisms (4 papers) and Gene expression and cancer classification (4 papers). The work is most often cited by research in Cancer Research (514 citations), Oncology (857 citations), Reproductive Medicine (239 citations), Pathology and Forensic Medicine (257 citations) and Pharmacology (80 citations). Richard A. Bender has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Don V. Jackson, Robert C. Young, Bruce A. Chabner, Manford C. Castle, Richard I. Fisher, Mark G. Erlander, Vincent T. DeVita, Tom Anderson, Vincent T. Oliverio and Susan P. Hubbard. Their work appears in journals such as Journal of Clinical Oncology, Cancer, American Journal of Hematology, Blood and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.